Kosh Agarwal
0000-0002-4754-828X
405 papers found
Refreshing results…
Tenofovir-based combination therapy for HIV/HBV co-infection
408 HBsAg AND IP-10 PLASMA LEVELS KINETICS DURING THERAPY WITH PEGYLATED INTERFERON AND CONSEQUENT THERAPY WITH NUCLEOS(T)IDE ANALOGUES
738 Switch From Long-Term De-Novo Lamivudine + Adefovir Therapy to Tenofovir Or/And Entecavir Improves Viral Response and Renal/Bone Safety
905 ADHERENCE WITH TELAPREVIR BID vs. Q8h DOSING IN TREATMENT-NAÏVE HCV-INFECTED PATIENTS: RESULTS FROM THE PHASE III OPTIMIZE STUDY
Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation
Review article: The treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients
STARTVerso3: A randomized, double-blind, placebo-controlled Phase III trial of faldaprevir in combination with pegylated interferon alfa-2a and ribavirin in treatment-experienced patients with chronic hepatitis C genotype-1 infection
Impact of Baseline Steatosis and Severity of Ischaemia-Reperfusion Injury in Predicting HCV Recurrence Post Liver Transplantation
Viral Hepatitis ( plus Antiviral Therapy) Real world experience of treating difficult to-treat genotype 1 HCV patients with protease inhibitor
Viral response in long-term therapy with nucleos(t)ide analogues in chronic hepatitis B cirrhosis prevents decompensation
Monitoring of Plasma Ribavirin-Data From a TDM Laboratory 2011 to Present
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial
Outpatient Liver Transplant Assessments Are Safe and Cost-Effective When Compared to Inpatient Liver Transplant Assessments in Carefully Selected Patients
Chronic hepatitis B in pregnancy - can virological, serological and immunological markers during pregnancy predict post delivery hepatic flares?
HBsAg pre-treatment levels and therapy kinetics - marker of HBV viral control in HBV/HIV co-infected patients treated with tenofovir
Use of ribavirin monitoring to predict significant anaemia in patients being treated for Hepatitis C
Increase in inducible interferon-gamma protein 10 (IP10) during long-term therapy with nucleos(t)ide analogues in chronic hepatitis B predicts efficient viral suppression
Viral Hepatitis ( plus Antiviral Therapy) A real life experience of protease inhibitor: direct comparison of Boceprevir and Telaprevir
Low Relapse Rate Leads to High Concordance of SVR4 and SVR12 with SVR24 After Treatment with ABT-450/r, ABT-267, ABT-333+Ribavirin in Patients with Chronic HCV Genotype 1 Infection in the AVIATOR Study
Viral Hepatitis ( plus Antiviral Therapy) 'Real world' experience of adverse events in patients undergoing protease inhibitor therapy in HCV
Missing publications? Search for publications with a matching author name.